← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

CGNX logoCognex Corporation(CGNX)Earnings, Financials & Key Ratios

CGNX•NASDAQ
$62.26
$10.4B mkt cap·91.6× P/E·Price updated May 6, 2026
SectorTechnologyIndustryTech Hardware & EquipmentSub-IndustryMachine Vision, Imaging and Lidar
AboutCognex Corporation provides machine vision products that capture and analyze visual information in order to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process. The company offers VisionPro software, a suite of patented vision tools for advanced programming; QuickBuild that allows customers to build vision applications with a graphical, flowchart-based programming interface; and Cognex deep learning vision software. It also provides a range of inspection tasks, including part location, identification, measurement, assembly verification, and robotic guidance; vision sensors for vision applications, such as checking the presence and size of parts; and the In-Sight product line of vision systems and sensors. In addition, the company offers DataMan, an image-based barcode readers and barcode verifiers. It sells its products to consumer electronics, automotive, consumer products, food and beverage, pharmaceuticals, and medical devices industries, as well as through a network of distributors and integrators. Cognex Corporation was incorporated in 1981 and is headquartered in Natick, Massachusetts.Show more
  • Revenue$994M+8.7%
  • EBITDA$193M+30.9%
  • Net Income$114M+7.8%
  • EPS (Diluted)0.68+9.7%
  • Gross Margin66.92%-2.2%
  • EBITDA Margin19.45%+20.4%
  • Operating Margin16.35%+29.9%
  • Net Margin11.51%-0.9%
  • ROE7.61%+8.3%
  • ROIC9.01%+45.2%
  • Debt/Equity0.05+10.9%
Analysis→Technical→

CGNX Key Insights

Cognex Corporation (CGNX) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Strong Piotroski F-Score: 7/9
  • ✓FCF machine: 23.8% free cash flow margin
  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Healthy 5Y average net margin of 17.0%
  • ✓Trading near 52-week high

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

CGNX Price & Volume

Cognex Corporation (CGNX) stock price & volume — 10-year historical chart

Loading chart...

CGNX Growth Metrics

Cognex Corporation (CGNX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years8.24%
5 Years4.16%
3 Years-0.39%
TTM8.73%

Profit CAGR

10 Years-4.8%
5 Years-8.27%
3 Years-19.02%
TTM7.79%

EPS CAGR

10 Years-4.43%
5 Years-7.42%
3 Years-17.93%
TTM9.91%

Return on Capital

10 Years13.35%
5 Years10.83%
3 Years7.44%
Last Year8.89%

CGNX Recent Earnings

Cognex Corporation (CGNX) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 10/12 qtrs (83%)
Q1 2026Latest
Feb 11, 2026
EPS
$0.27
Est $0.22
+22.7%
Revenue
$252M
Est $239M
+5.6%
Q4 2025
Oct 29, 2025
EPS
$0.33
Est $0.27
+22.2%
Revenue
$277M
Est $239M
+15.9%
Q3 2025
Jul 30, 2025
EPS
$0.25
Est $0.23
+8.7%
Revenue
$249M
Est $248M
+0.4%
Q2 2025
Apr 30, 2025
EPS
$0.16
Est $0.13
+23.1%
Revenue
$216M
Est $249M
-13.2%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q1 2026LatestFeb 11, 2026
$0.27vs $0.22+22.7%
$252Mvs $239M+5.6%
Q4 2025Oct 29, 2025
$0.33vs $0.27+22.2%
$277Mvs $239M+15.9%
Q3 2025Jul 30, 2025
$0.25vs $0.23+8.7%
$249Mvs $248M+0.4%
Q2 2025Apr 30, 2025
$0.16vs $0.13+23.1%
$216Mvs $249M-13.2%
Based on last 12 quarters of dataView full earnings history →

CGNX Peer Comparison

Cognex Corporation (CGNX) competitors in Machine Vision, Imaging and Lidar — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
KEYS logoKEYSKeysight Technologies, Inc.Direct Competitor62.89B366.6875.147.95%16.88%15.44%0.51
COHU logoCOHUCohu, Inc.Direct Competitor2.33B49.62-31.2112.74%-11.54%-6.84%0.46
VIAV logoVIAVViavi Solutions Inc.Direct Competitor12.26B53.00353.338.39%-4.03%-6.92%0.89
NOVT logoNOVTNovanta Inc.Direct Competitor4.95B138.9094.493.3%5.49%4.1%0.26
KLIC logoKLICKulicke and Soffa Industries, Inc.Product Competitor4.91B93.789999-7.38%7.16%6.59%0.05
MKSI logoMKSIMKS Inc.Product Competitor19.78B293.7767.229.62%7.51%11.54%1.73
CEVA logoCEVACEVA, Inc.Product Competitor832.42M34.66-93.689.77%-10.49%-4.2%0.02
TRMB logoTRMBTrimble Inc.Product Competitor15.02B63.4236.24-2.61%12.37%7.95%0.24

Compare CGNX vs Peers

Cognex Corporation (CGNX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs KEYS

Most directly comparable listed peer for CGNX.

Scale Benchmark

vs NVDA

Larger-name benchmark to compare CGNX against a more recognizable public peer.

Peer Set

Compare Top 5

vs KEYS, COHU, VIAV, NOVT

CGNX Income Statement

Cognex Corporation (CGNX) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Sales/Revenue766.08M806.34M725.63M811.02M1.04B1.01B837.55M914.51M994.36M
Revenue Growth %44.68%5.25%-10.01%11.77%27.88%-2.99%-16.75%9.19%8.73%
Cost of Goods Sold187.29M206.05M189.75M206.42M277.27M284.19M236.31M288.72M328.97M
COGS % of Revenue24.45%25.55%26.15%25.45%26.74%28.25%28.21%31.57%33.08%
Gross Profit
578.79M▲ 0%
600.29M▲ 3.7%
535.87M▼ 10.7%
604.6M▲ 12.8%
759.83M▲ 25.7%
721.9M▼ 5.0%
601.24M▼ 16.7%
625.79M▲ 4.1%
665.39M▲ 6.3%
Gross Margin %75.55%74.45%73.85%74.55%73.26%71.75%71.79%68.43%66.92%
Gross Profit Growth %45.26%3.71%-10.73%12.83%25.67%-4.99%-16.71%4.08%6.33%
Operating Expenses319.93M379.14M393.27M434.07M444.73M475.68M470.54M510.73M502.83M
OpEx % of Revenue41.76%47.02%54.2%53.52%42.88%47.28%56.18%55.85%50.57%
Selling, General & Admin220.73M262.7M273.84M267.59M309.35M312.11M339.14M370.91M363.86M
SG&A % of Revenue28.81%32.58%37.74%32.99%29.83%31.02%40.49%40.56%36.59%
Research & Development99.2M116.44M119.43M130.98M135.37M141.13M139.4M139.81M138.97M
R&D % of Revenue12.95%14.44%16.46%16.15%13.05%14.03%16.64%15.29%13.98%
Other Operating Expenses00035.49M022.44M-8M00
Operating Income
258.86M▲ 0%
221.14M▼ 14.6%
142.6M▼ 35.5%
170.53M▲ 19.6%
315.1M▲ 84.8%
246.23M▼ 21.9%
130.7M▼ 46.9%
115.06M▼ 12.0%
162.57M▲ 41.3%
Operating Margin %33.79%27.43%19.65%21.03%30.38%24.47%15.61%12.58%16.35%
Operating Income Growth %68.02%-14.57%-35.52%19.58%84.78%-21.86%-46.92%-11.96%41.28%
EBITDA275.85M242.69M167.5M197.03M335.38M265.85M152.58M147.75M193.36M
EBITDA Margin %36.01%30.1%23.08%24.29%32.34%26.42%18.22%16.16%19.45%
EBITDA Growth %63.1%-12.02%-30.98%17.63%70.22%-20.73%-42.61%-3.16%30.87%
D&A (Non-Cash Add-back)16.99M21.55M24.9M26.5M20.28M19.62M21.88M32.69M30.79M
EBIT258.86M221.14M142.6M206.02M315.1M268.67M122.7M115.06M162.57M
Net Interest Income000000000
Interest Income000000000
Interest Expense000000000
Other Income/Expense7.6M13.43M20.39M16.38M3.8M4.47M4.65M16.42M20.24M
Pretax Income
266.46M▲ 0%
234.57M▼ 12.0%
162.99M▼ 30.5%
186.91M▲ 14.7%
318.9M▲ 70.6%
250.69M▼ 21.4%
135.35M▼ 46.0%
131.49M▼ 2.9%
182.8M▲ 39.0%
Pretax Margin %34.78%29.09%22.46%23.05%30.75%24.92%16.16%14.38%18.38%
Income Tax89.75M15.31M-40.87M10.72M39.02M35.17M22.11M25.32M68.36M
Effective Tax Rate %33.68%6.53%-25.08%5.74%12.24%14.03%16.34%19.25%37.4%
Net Income
176.71M▲ 0%
219.27M▲ 24.1%
203.87M▼ 7.0%
176.19M▼ 13.6%
279.88M▲ 58.9%
215.53M▼ 23.0%
113.23M▼ 47.5%
106.17M▼ 6.2%
114.44M▲ 7.8%
Net Margin %23.07%27.19%28.1%21.72%26.99%21.42%13.52%11.61%11.51%
Net Income Growth %22.98%24.08%-7.02%-13.58%58.86%-22.99%-47.46%-6.24%7.79%
Net Income (Continuing)176.71M219.27M203.87M176.19M279.88M215.53M113.23M106.17M114.44M
Discontinued Operations000000000
Minority Interest000000000
EPS (Diluted)
0.99▲ 0%
1.24▲ 25.3%
1.16▼ 6.5%
1.00▼ 13.8%
1.56▲ 56.0%
1.23▼ 21.2%
0.65▼ 47.2%
0.62▼ 4.6%
0.68▲ 9.7%
EPS Growth %15.12%25.25%-6.45%-13.79%56%-21.15%-47.15%-4.62%9.68%
EPS (Basic)1.021.271.191.021.591.240.660.620.68
Diluted Shares Outstanding179.55M177.41M175.27M176.59M179.92M174.87M173.4M172.61M169.37M
Basic Shares Outstanding173.29M172.33M171.19M173.49M176.46M173.41M172.25M171.44M168.05M
Dividend Payout Ratio16.43%14.53%17.23%221.65%15.46%21.31%43.34%49.29%47.73%

CGNX Balance Sheet

Cognex Corporation (CGNX) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Total Current Assets629.99M780.33M607.23M601.69M639.8M717.7M679M613.37M697.25M
Cash & Short-Term Investments404.54M535.56M411.9M372.31M323.62M400.13M332.05M246.05M336.96M
Cash Only106.58M108.21M171.43M269.07M186.16M181.37M202.66M186.09M262.93M
Short-Term Investments297.96M427.35M240.47M103.24M137.46M218.76M129.39M59.96M74.04M
Accounts Receivable126.84M127.48M108.23M131.33M134.34M127.6M116.57M146.41M163.69M
Days Sales Outstanding60.4357.7154.4459.147.2846.2950.858.4460.09
Inventory67.92M83.28M60.26M60.83M113.1M122.48M162.28M157.53M137.89M
Days Inventory Outstanding132.37147.53115.91107.56148.89157.31250.67199.15152.99
Other Current Assets0000067.49M68.1M63.38M58.7M
Total Non-Current Assets657.76M509.34M1.28B1.2B1.36B1.24B1.34B1.38B1.32B
Property, Plant & Equipment78.05M91.4M106.97M101.75M100.7M117.4M180.96M165.77M158.32M
Fixed Asset Turnover9.82x8.82x6.78x7.97x10.30x8.57x4.63x5.52x6.28x
Goodwill113.21M113.21M243.44M244.08M241.71M242.63M393.18M384.94M386.28M
Intangible Assets13.19M10.11M39.49M15.55M11.89M12.41M112.95M90.68M81.1M
Long-Term Investments423.44M262.04M433.45M395.13M583.75M454.12M244.23M340.9M305.34M
Other Non-Current Assets2.49M3.92M5.83M7.79M7.24M6.64M7.09M5.03M4.99M
Total Assets
1.29B▲ 0%
1.29B▲ 0.1%
1.89B▲ 46.2%
1.8B▼ 4.5%
2B▲ 11.3%
1.96B▼ 2.3%
2.02B▲ 3.0%
1.99B▼ 1.2%
2.02B▲ 1.2%
Asset Turnover0.59x0.63x0.38x0.45x0.52x0.51x0.42x0.46x0.49x
Asset Growth %24%0.14%46.23%-4.52%11.27%-2.27%3.05%-1.24%1.19%
Total Current Liabilities112.64M91.36M120.48M132.3M188.59M187.71M151.88M169.38M183.55M
Accounts Payable23.46M16.23M17.87M16.27M44.05M27.1M21.45M38.05M50.2M
Days Payables Outstanding45.7328.7534.3728.7757.9934.8133.1448.155.7
Short-Term Debt000000000
Deferred Revenue (Current)9.42M9.85M14.43M21.27M35.74M40.79M31.52M25.04M21.09M
Other Current Liabilities14.98M11.27M10.86M41.23M50.92M49.4M27.72M34.32M51.89M
Current Ratio5.59x8.54x5.04x4.55x3.39x3.82x4.47x3.62x3.80x
Quick Ratio4.99x7.63x4.54x4.09x2.79x3.17x3.40x2.69x3.05x
Cash Conversion Cycle147.08176.48135.99137.9138.18168.79268.33209.48157.38
Total Non-Current Liabilities79.44M63.05M409.75M406.2M384.98M332.04M361.18M305.96M341.1M
Long-Term Debt000000000
Capital Lease Obligations0012.33M18.12M17.8M31.3M68.98M61.36M64.87M
Deferred Tax Liabilities6.8M8.07M343.91M329.21M308.55M265.83M273.56M243.52M274.78M
Other Non-Current Liabilities72.64M54.98M53.52M58.87M58.64M34.91M18.64M1.08M1.45M
Total Liabilities192.52M154.4M530.23M538.5M573.57M519.75M513.06M475.35M524.65M
Total Debt0017.97M26.23M25.58M39.75M78.6M70.22M76.59M
Net Debt-106.58M-108.21M-153.46M-242.84M-160.58M-141.62M-124.05M-115.88M-186.34M
Debt / Equity--0.01x0.02x0.02x0.03x0.05x0.05x0.05x
Debt / EBITDA--0.11x0.13x0.08x0.15x0.52x0.48x0.40x
Net Debt / EBITDA-0.39x-0.45x-0.92x-1.23x-0.48x-0.53x-0.81x-0.78x-0.96x
Interest Coverage---------
Total Equity
1.1B▲ 0%
1.14B▲ 3.6%
1.36B▲ 19.4%
1.26B▼ 6.9%
1.43B▲ 13.3%
1.44B▲ 0.6%
1.5B▲ 4.6%
1.52B▲ 0.8%
1.49B▼ 1.7%
Equity Growth %13.79%3.64%19.42%-6.9%13.3%0.58%4.61%0.85%-1.69%
Book Value per Share6.106.407.747.157.958.238.688.798.81
Total Shareholders' Equity1.1B1.14B1.36B1.26B1.43B1.44B1.5B1.52B1.49B
Common Stock347K342K345K352K351K345K343K341K334K
Retained Earnings668.27M646.21M753.27M487.91M562.88M528.18M512.54M499.3M406.36M
Treasury Stock000000000
Accumulated OCI-34.6M-40.5M-37.27M-33.8M-47.94M-69.3M-45.34M-72.78M-53.5M
Minority Interest000000000

CGNX Cash Flow Statement

Cognex Corporation (CGNX) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Cash from Operations224.32M223.45M253.31M242.4M314.06M243.41M112.92M149.08M245.51M
Operating CF Margin %29.28%27.71%34.91%29.89%30.28%24.19%13.48%16.3%24.69%
Operating CF Growth %23.2%-0.39%13.36%-4.31%29.56%-22.5%-53.61%32.03%64.69%
Net Income177.18M219.27M203.87M176.19M279.88M215.53M113.23M106.17M114.44M
Depreciation & Amortization16.99M21.55M24.9M26.5M20.28M19.62M21.88M32.69M30.79M
Stock-Based Compensation31.94M41.09M45.59M42.66M43.77M54.51M54.77M52.44M48.52M
Deferred Taxes1.79M-413K-94.87M-3.35M-3.12M-27.34M-19.78M-21.51M40.15M
Other Non-Cash Items-183K-396K2.15M31.76M7.26M54.63M10.53M4.13M9.87M
Working Capital Changes-3.39M-57.64M71.67M-31.36M-34.01M-73.53M-67.72M-24.85M1.75M
Change in Receivables-55.19M-1.87M20.34M-22.13M-2.87M5.26M23.09M-32.13M-15.23M
Change in Inventory-37.09M-16.95M17.84M-10.32M-54.92M-48.93M3.77M2.5M4.86M
Change in Payables12.32M-7.25M1.63M-1.69M27.83M-17.28M-13.74M18.35M11.71M
Cash from Investing-105.56M-10.83M-157.34M169.44M-252.54M-4.45M32.27M-38.97M28.02M
Capital Expenditures-28.75M-37.09M-21.75M-13.3M-15.46M-19.67M-23.08M-15.04M-8.74M
CapEx % of Revenue3.75%4.6%3%1.64%1.49%1.95%2.76%1.64%0.88%
Acquisitions-24.12M-4.26M-166.91M1M0-5.05M-257.06M-1.44M6.7M
Investments---------
Other Investing-291K30.53M00000-8K156K
Cash from Financing-100.12M-209.9M-32.23M-316.87M-141.62M-240.37M-125.61M-118.42M-206.69M
Debt Issued (Net)000000000
Equity Issued (Net)-69.16M-177.04M-61.69M-51.04M-161.65M-204.31M-79.79M-67.08M-151.68M
Dividends Paid-29.04M-31.86M-35.12M-390.51M-43.26M-45.92M-49.08M-52.33M-54.63M
Share Repurchases-123.72M-203.82M-61.69M-51.04M-161.65M-204.31M-79.79M-67.08M-151.23M
Other Financing-1.93M-1M64.58M124.68M63.29M9.86M3.27M994K-388K
Net Change in Cash
26.94M▲ 0%
1.63M▼ 93.9%
63.22M▲ 3778.5%
97.64M▲ 54.5%
-82.91M▼ 184.9%
-4.79M▲ 94.2%
21.28M▲ 544.6%
-16.56M▼ 177.8%
76.83M▲ 563.9%
Free Cash Flow
195.57M▲ 0%
186.36M▼ 4.7%
231.57M▲ 24.3%
229.1M▼ 1.1%
298.61M▲ 30.3%
223.74M▼ 25.1%
89.84M▼ 59.8%
134.04M▲ 49.2%
236.77M▲ 76.6%
FCF Margin %25.53%23.11%31.91%28.25%28.79%22.24%10.73%14.66%23.81%
FCF Growth %15.54%-4.71%24.26%-1.07%30.34%-25.07%-59.85%49.2%76.64%
FCF per Share1.091.051.321.301.661.280.520.781.40
FCF Conversion (FCF/Net Income)1.27x1.02x1.24x1.38x1.12x1.13x1.00x1.40x2.15x
Interest Paid000000000
Taxes Paid000000000

CGNX Key Ratios

Cognex Corporation (CGNX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2016201720182019202020212022202320242025
Return on Equity (ROE)16.07%17.17%19.66%16.37%13.46%20.79%15.03%7.69%7.03%7.61%
Return on Invested Capital (ROIC)13.95%20.75%16.46%9.6%11.51%20.65%14.39%7.32%6.2%9.01%
Gross Margin75.25%75.55%74.45%73.85%74.55%73.26%71.75%71.79%68.43%66.92%
Net Margin27.14%23.07%27.19%28.1%21.72%26.99%21.42%13.52%11.61%11.51%
Debt / Equity---0.01x0.02x0.02x0.03x0.05x0.05x0.05x
FCF Conversion1.27x1.27x1.02x1.24x1.38x1.12x1.13x1.00x1.40x2.15x
Revenue Growth17.52%44.68%5.25%-10.01%11.77%27.88%-2.99%-16.75%9.19%8.73%

CGNX SEC Filings & Documents

Cognex Corporation (CGNX) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 6, 2026·SEC

Material company update

Apr 30, 2026·SEC

Material company update

Feb 17, 2026·SEC

10-K Annual Reports

4
FY 2026

Feb 12, 2026·SEC

FY 2025

Feb 13, 2025·SEC

FY 2024

Feb 15, 2024·SEC

10-Q Quarterly Reports

6
FY 2025

Oct 30, 2025·SEC

FY 2025

Jul 31, 2025·SEC

FY 2025

May 1, 2025·SEC

CGNX Frequently Asked Questions

Cognex Corporation (CGNX) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Cognex Corporation (CGNX) reported $994.4M in revenue for fiscal year 2025. This represents a 710% increase from $122.8M in 1996.

Cognex Corporation (CGNX) grew revenue by 8.7% over the past year. This is steady growth.

Yes, Cognex Corporation (CGNX) is profitable, generating $114.4M in net income for fiscal year 2025 (11.5% net margin).

Dividend & Returns

Yes, Cognex Corporation (CGNX) pays a dividend with a yield of 0.52%. This makes it attractive for income-focused investors.

Cognex Corporation (CGNX) has a return on equity (ROE) of 7.6%. This is below average, suggesting room for improvement.

Cognex Corporation (CGNX) generated $236.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More CGNX

Cognex Corporation (CGNX) financial analysis — history, returns, DCA and operating performance tools

Full CGNX Stock Analysis

Analyst verdict, bull/bear case, risk factors and peer comparison

→

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.